Detalhe da pesquisa
1.
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.
Blood
; 141(11): 1265-1276, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265087
2.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.
Am J Hematol
; 99(2): E32-E36, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994196
3.
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.
Proc Natl Acad Sci U S A
; 118(22)2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050021
4.
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study.
Blood
; 137(20): 2827-2837, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33881523
5.
A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia.
Blood
; 137(4): 524-532, 2021 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871585
6.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
7.
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.
Haematologica
; 108(7): 1793-1802, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779592
8.
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.
Haematologica
; 108(12): 3287-3297, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891751
9.
Hepatic haemophagocytosis in haematology patients with hepatic dysfunction: prognostic impact and contribution of liver biopsy combined with the haemophagocytic syndrome diagnostic score (HScore).
Br J Haematol
; 199(1): 106-116, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35968907
10.
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
Br J Haematol
; 198(3): 535-544, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438802
11.
Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: A nationwide population-based cohort.
Int J Cancer
; 148(2): 375-384, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32683691
12.
Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Haematologica
; 106(5): 1414-1422, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626866
13.
Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional status.
Eur J Haematol
; 106(6): 859-867, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33733520
14.
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial.
Eur J Haematol
; 107(1): 111-121, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765335
15.
Targeted molecular characterization shows differences between primary and secondary myelofibrosis.
Genes Chromosomes Cancer
; 59(1): 30-39, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340059
16.
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 105(6): 1507-1516, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241850
17.
Myelodysplastic Syndromes: How to Recognize Risk and Avoid Acute Myeloid Leukemia Transformation.
Curr Oncol Rep
; 22(1): 4, 2020 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31974774
18.
MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemia.
Future Oncol
; 16(13): 807-815, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32167393
19.
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.
Biol Blood Marrow Transplant
; 25(9): 1803-1809, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128325
20.
Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.
N Engl J Med
; 375(11): 1044-53, 2016 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27626518